Pharmaceutical Executive: June 2024 Issue (PDF)

Feature
Article
Pharmaceutical ExecutivePharmaceutical Executive: June 2024
Volume 44
Issue 6

Click the title above for a link to open the Pharmaceutical Executive June 2024 issue in an interactive PDF format.

June 2024
Download Issue PDF
Articles in this issue
Beyond the Numbers: Extrapolating Today’s Trends Forward
Beyond the Numbers: Extrapolating Today’s Trends Forward
Pharmaceutical Executive: June 2024 Issue (PDF)
Pharmaceutical Executive: June 2024 Issue (PDF)
Opposite Spectrums
Opposite Spectrums
2024 Pharm Exec Top 50 Companies
2024 Pharm Exec Top 50 Companies
Craig Tooman: Silencing the Distractions
Craig Tooman: Silencing the Distractions
Regaining Trust in the Pharma Industry
Regaining Trust in the Pharma Industry
Succession Attack Plan: Get Strategic with Your Critical Roles
Succession Attack Plan: Get Strategic with Your Critical Roles
The Healthcare System is Changing—So How Should We Respond?
The Healthcare System is Changing—So How Should We Respond?
Biotech Performance Remains Tethered to Rate Expectations
Biotech Performance Remains Tethered to Rate Expectations
Pharm Exec Exclusive: Mark Cuban Talks Drug Pricing
Pharm Exec Exclusive: Mark Cuban Talks Drug Pricing
Ray Kingman
From Identity to Margin: Securing Audience Measurement in Pharma Marketing
Recent Videos
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Most Effective Strategies to Close the Innovation Gap in Women’s Health
Root Causes of Innovation Gap in Women’s Health
Fred Aslan
Gameto - Addressing Regulatory Hurdles in iPSC-Based Fertility
Related Content
Merck Reaches Licensing Agreement with Jiangsu Hengrui for Novel Heart Disease Drug

Merck Reaches Licensing Agreement with Jiangsu Hengrui for Novel Heart Disease Drug

Don Tracy, Associate Editor
March 25th 2025
Article

Under terms of the deal, Merck will gain global rights to develop, manufacture, and commercialize HRS-5346 for cardiovascular disease, excluding Greater China.

Peter Ax, UpScriptHealth

Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals

Miranda Schmalfuhs
March 24th 2025
Podcast

Peter Ax, founder & CEO of UpScriptHealth, discusses the impact of tariffs on the pharmaceutical industry and how digital health platforms could potentially help offset them.

Stock.adobe.com

USPTO Grants Notice of Allowance to Anixa Bioscience’s Ovarian Cancer Vaccine

Mike Hollan
March 25th 2025
Article

The potential vaccine is being developed in partnership with the Cleveland Clinic and the NCI.

Jennifer Butler

The Misinformation Maze: Navigating Public Health in the Digital Age

Miranda Schmalfuhs
March 11th 2025
Podcast

Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.

Pharma Pulse 3/25/25: The Unfinished Work of Healthcare Reform, Preventing Adverse Drug Events & more

Pharma Pulse 3/25/25: The Unfinished Work of Healthcare Reform, Preventing Adverse Drug Events & more

Miranda Schmalfuhs
March 25th 2025
Article

The latest news for pharma industry insiders.

The 8 Market Access Performance Metrics You Should Be Tracking

Access Infinity
March 25th 2025
Article

This guide offers an in-depth analysis of the essential KPIs that market access teams should track to measure success particularly across speed of access, breadth of access, and price performance. It includes real-life use cases and practical steps on how to get started.